• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Takeda Receives 1st Stem Cell-Derived CAR-T From Kyoto University Collaboration

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 16, 2019 at 12:12: PM
via Four years ago, Takeda Pharmaceutical Company and The Center for iPS Cell Research and Application (CiRA) at Kyoto University established a 10-year joint research program. Today, the two organizations announced that Kyoto University was transferring the first novel induced pluripotent stem (iPS) cell-derived chimeric antigen receptor (CAR-T) therapy to Takeda.

article source
 

<



Similar threads

cafead
Takeda’s Entyvio receives FDA approval for subcutaneous administration
Replies
0
Views
172
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
US allows increased production of Takeda&#039;s ADHD drug to address shortage
Replies
0
Views
17
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
With a new oncology head, Takeda revamps its R&amp;D strategy
Replies
0
Views
39
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Lundbeck leaves Trintellix to partner Takeda in the US, opting for royalties as it focuses efforts on Rexulti
Replies
0
Views
17
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Takeda takes $140M charge on failed epilepsy drug, while touting continued FDA potential
Replies
0
Views
23
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote